A human tissue screen identifies a regulator of ER secretion as a brain-size determinant

94Citations
Citations of this article
353Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Loss-of-function (LOF) screens provide a powerful approach to identify regulators in biological processes. Pioneered in laboratory animals, LOF screens of human genes are currently restricted to two-dimensional cell cultures, which hinders the testing of gene functions requiring tissue context. Here, we present CRISPR-lineage tracing at cellular resolution in heterogeneous tissue (CRISPR-LICHT), which enables parallel LOF studies in human cerebral organoid tissue. We used CRISPR-LICHT to test 173 microcephaly candidate genes, revealing 25 to be involved in known and uncharacterized microcephaly-associated pathways. We characterized IER3IP1, which regulates the endoplasmic reticulum (ER) function and extracellular matrix protein secretion crucial for tissue integrity, the dysregulation of which results in microcephaly. Our human tissue screening technology identifies microcephaly genes and mechanisms involved in brain-size control.

Cite

CITATION STYLE

APA

Esk, C., Lindenhofe, D., Haendeler, S., Wester, R. A., Pflug, F., Schroeder, B., … Knoblich, J. A. (2020). A human tissue screen identifies a regulator of ER secretion as a brain-size determinant. Science, 370(6519), 935–941. https://doi.org/10.1126/science.abb5390

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free